To view the PDF file, sign up for a MySharenet subscription.

ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by a Director and Prescribed Officer

Release Date: 27/05/2024 16:15
Code(s): APN     PDF:  
Wrap Text
Dealing in Securities by a Director and Prescribed Officer

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) ("Aspen Holdings")
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively "Aspen" or "the Group")

DEALING IN SECURITIES BY A DIRECTOR AND PRESCRIBED OFFICER

In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, shareholders are
advised of the dealings in securities as set out below.

Deferred bonus shares, awarded in 2019 in respect of the Long-term Retention Share Scheme, a
component of the Aspen South African Management Deferred Incentive Bonus Scheme, have vested
and have been delivered to the undermentioned director and prescribed officer.

DIRECTOR

Director                        :    Sean Matthew Capazorio
Company                         :    Aspen Pharmacare Holdings Limited
Date of transaction             :    23 May 2024
Nature of transaction           :    Off-market, automatic delivery of vested shares in terms of the Long-
                                     term Retention Share Scheme and subsequent on-market sale to
                                     settle the tax liability
Number of securities vested     :    34 126
Price on vesting                :    R231.30
Value of vesting                :    R7 893 343.80
Number of shares sold           :    15 868
Sale price (weighted average)   :    R229.97
Highest sale price              :    R232.73
Lowest sale price                :   R228.82
Value of sale                   :    R3 649 262.34
Class of securities             :    Ordinary shares
Nature of interest              :    Direct beneficial
Clearance obtained              :    Yes


PRESCRIBED OFFICER

Director                        :    Lorraine Angela Hill
Company                         :    Aspen Pharmacare Holdings Limited
Date of transaction             :    23 May 2024
Nature of transaction           :    Off-market, automatic delivery of vested shares in terms of the Long-
                                     term Retention Share Scheme and subsequent on-market sale to
                                     settle the tax liability
Number of securities vested     :    34 126
Price on vesting                :    R231.30
Value of vesting                :    R7 893 343.80
Number of shares sold           :    15 868
Sale price (Weighted average)    :   R229.97
Highest sale Price              :    R232.73
Lowest sale Price               :    R228.82
Value of sale                   :    R3 649 262.34
Class of securities             :    Ordinary shares
Nature of interest              :    Direct beneficial
Clearance obtained              :    Yes

Durban
27 May 2024

Sponsor
Investec Bank Limited

Date: 27-05-2024 04:15:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.